BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1751677)

  • 1. Clinical experience of double filtration plasmapheresis for drug refractory neurological diseases.
    Ito Y; Odaka M; Tabata Y; Soeda K; Hayashi H; Kobayashi S; Sato T; Yamane S; Isono K
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):27-35. PubMed ID: 1751677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
    Gong D; Ji D; Xu B; Liu Z
    Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
    Bozkirli DE; Kozanoglu I; Bozkirli E; Yucel E
    J Clin Apher; 2013 Dec; 28(6):422-5. PubMed ID: 23908096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-filtration plasmapheresis combined with immunosuppressive treatment for severe pemphigus: 10 years' experience of a single center in China.
    Liu Y; Zhang B; Ma J; Wang H; Fan X; Zheng K; Chen L; Li X; Qin Y; Li L; Li X
    J Clin Apher; 2021 Feb; 36(1):20-27. PubMed ID: 32812668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.
    Chen Y; Yang L; Li K; Liu Z; Gong D; Zhang H; Liu Z; Hu W
    Ther Apher Dial; 2016 Apr; 20(2):183-8. PubMed ID: 26948291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
    J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration Plasmapheresis.
    Grupp C; Beckermann J; Köster E; Zewinger S; Knittel M; Walek T; Hohenstein B; Jaeger B; Spitthöver R; Klingel R; Fassbender CM; Tyczynski B
    Blood Purif; 2020; 49(4):457-467. PubMed ID: 32191938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
    Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
    Zhang YY; Tang Z; Chen DM; Gong DH; Ji DX; Liu ZH
    BMC Nephrol; 2014 Aug; 15():128. PubMed ID: 25086644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy.
    Ishikawa T; Higuchi K; Kubota T; Seki K; Honma T; Yoshida T; Kamimura T; Tasaki K; Hirose S; Suzuki Y
    Ther Apher Dial; 2011 Aug; 15(4):400-5. PubMed ID: 21884476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
    Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
    Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
    Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
    Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of double filtration plasmapheresis on nocturnal respiratory function in myasthenic patients.
    Yeh JH; Lin CM; Chen WH; Chiu HC
    Artif Organs; 2013 Dec; 37(12):1076-9. PubMed ID: 23865547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
    Wang T; Xu B; Fan R; Liu Z; Gong D
    J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.
    Kim JY; Park JS; Park JC; Kim ME; Nahm DH
    Ther Apher Dial; 2013 Dec; 17(6):631-7. PubMed ID: 24330559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis.
    Dong J; Huang L; Li C; Wu B; Yang X; Ge Y
    Lupus; 2023 Aug; 32(9):1066-1074. PubMed ID: 37487569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.